Video: Essure Removal Tips

A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.

Patients with 3 or more adverse pregnancy outcomes had lower odds of postpartum contraceptive use in a PRAMS analysis of 222,412 individuals.

This FAQ summarizes a Special Report discussion on testosterone pellet therapy in women and advice for hesitant prescribers.

This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.

This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.

This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.

Blood levels alone cannot confirm safe testosterone dosing. Asking about androgenic effects and allowing months for response are central to care.

A global consensus defines what the evidence supports for testosterone in women. Benefits for strength, mood, and cognition lack randomized data.